ASH 2016: Multiple Myeloma Overview - Dr. Paul Richardson

Paul Richardson, MD
Dana-Farber Cancer Institute
Boston, MA, USA

Dr. Paul Richardson summarizes the key takeways in trends in myeloma treatments from the 58th Annual American Society of Hematology meeting. As he points out, the important message from these recent studies is that there is "continued progress, continued refinement of treatment strategies informed by important randomized trials, and continued advances in science."